Beijing Aosaikang Pharm (002755.SZ) traded flat 0 % during a 24 hours period ending at 07:37 PM Central Europe on Monday 26th. One Beijing Aosaikang Pharm stock can currently be bought for about CNY 12.28 on popular exchanges. Current supply of Beijing Aosaikang Pharm stocks is 928.1 mn. Beijing Aosaikang Pharm has a current market capitalization of CNY 11.2 bn and approximately CNY 125.7 mn worth of Beijing Aosaikang Pharm was traded on exchanges in the last 24 hours. Since last month end, Beijing Aosaikang Pharm has traded -3.97 % down. Simple moving average of last 200 days is at CNY 13.01. The highest price of past 52 weeks was recorded at CNY 20.16 on 11/14/2025. 52 weeks low was at CNY 11.02 on 09/11/2026.
Here is how related stocks have performed in the past 24 hours:
Shenzhen Bluetrum Technolo (688332.SS) traded flat 0 % and now trades at CNY 73.12. Current market capitalisation for Shenzhen Bluetrum Technolo is CNY 13.4 bn.
Suzhou Tztek (688003.SS) traded flat 0 % and now trades at CNY 67.6. Suzhou Tztek has a market capitalisation of CNY 13.4 bn. Suzhou Tztek has a current price to earnings ratio of 69.76. Suzhou TZTEK Technology Co. reported a notable rise in revenue during the first three quarters of 2026, with a significant increase in newly signed orders. The company’s earnings before non‑core items turned profitable, reflecting a turnaround in its profitability trajectory. Growth in the order book, both in terms of new contracts and existing commitments, suggests a strengthening demand for its products and services. Analysts note that the upward trend in revenue and orders could support the company’s expansion plans and contribute to a more robust financial position in the near term.
Kunshan Dongwei (688700.SS) traded flat 0 % and now trades at CNY 40.9. Current market capitalisation for Kunshan Dongwei is CNY 13.4 bn. Kunshan Dongwei has a current price to earnings ratio of 73.36. Kunshan Dongwei Technology A reported its most recent quarterly results at a three‑month financial conference. The company posted earnings per share that exceeded the same period last year, indicating an improvement in profitability. Revenue for the quarter was higher than the same quarter previously, reflecting a growth trend. The statement highlighted the company’s positive financial performance, with both earnings and sales showing upward momentum compared with the prior year.
Wuhan Yangtze Communicatio (600345.SS) traded flat 0 % and now trades at CNY 38.67. Wuhan Yangtze Communicatio has a market capitalisation of CNY 13.4 bn. Wuhan Yangtze Communicatio has a current price to earnings ratio of 21.66.
Anhui Anke Biotechnology G (300009.SZ) traded flat 0 % and now trades at CNY 8.02. Anhui Anke Biotechnology G has a market capitalisation of CNY 13.4 bn. Anhui Anke Biotechnology G has a current price to earnings ratio of 19.16. Anhui Anke Biotechnology Group has reported a decline in its third‑quarter net profit, a trend that aligns with broader industry pressure. The company’s earnings fell by roughly forty‑percent year over year, reflecting tighter market conditions and possibly higher operating costs. Analysts note that the drop is part of a wider pattern of profitability challenges among biotech and life‑science firms. While the company has not yet announced specific strategic responses, market observers anticipate that management may focus on cost optimisation and product pipeline acceleration to counter the downturn. The development highlights the sector’s sensitivity to economic fluctuations and underscores the need for resilient revenue streams.
About Beijing Aosaikang Pharm
Beijing Aosaikang Pharmaceutical Co.,Ltd. is a health care company operating in the pharmaceutical industry. The company is based in Nanjing, China, and listed on the Shenzhen Stock Exchange. Beijing Aosaikang develops, manufactures, and markets digestive drugs, antitumor drugs, and related products. Additionally, it offers technology consulting and technology transfer services.